Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: October 16, 2026 at 12:45 AM UTC
| NCT Number | NCT06545955 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE3 |
| Target Enrollment | 250 participants |
| Active Locations | 40 sites in the US |
| Sponsor | Ferring Pharmaceuticals |
| Last Updated on CT.gov | September 25, 2026 (3 weeks ago) |
As of October 16, 2026: Clinical trial NCT06545955 is currently recruiting participants. This phase3 study for bladder cancer is actively seeking new participants at 40 locations across the United States. The study is sponsored by Ferring Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06545955 is actively recruiting participants as of October 16, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 40 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06545955 was last updated 3 weeks ago (September 25, 2026). HelloStudys verifies this status automatically.